Optimal treatment of laryngopharyngeal reflux disease
نویسندگان
چکیده
منابع مشابه
Treatment of clinically diagnosed laryngopharyngeal reflux disease.
OBJECTIVES To determine the incidence of Helicobacter pylori (HP) stool antigen (HPSA) in patients with laryngopharyngeal reflux disease (LPRD), and to make a comparison of 2 treatment regimens that have been used based on the presence or absence of HPSA positivity in patients with LPRD. DESIGN Randomized controlled study. SETTING Suez Canal University Hospital, Ismalia, Egypt. PATIENTS A...
متن کاملLaryngopharyngeal Reflux Disease – LPRD
INTRODUCTION Laryngopharyngeal reflux disease (LPRD) referes to an inflammatory reaction of the mucous membrane of pharynx, larynx and other associated respiratory organs, caused by a reflux of stomach contents into the esophagus. LPRD is considered to be a relatively new clinical entity with a vast number of clinical manifestations which are treated through different fields of medicine, often ...
متن کاملLaryngopharyngeal Reflux
1Department of Otolaryngology-Head Neck Surgery, Queen Alexandra Hospital, Portsmouth PO63LY, UK 2Department of Otolaryngology, Aristotle university of Thessaloniki, Thessaloniki, Greece 3Department of Otolaryngology-Head Neck Surgery, The Freeman Hospital, Newcastle Upon Tyne, UK 4Department of Otolaryngology-Head Neck Surgery, Schwarzwald-Baar Hospital, Villingen-Schwenningen, Germany 5Depart...
متن کاملLaryngopharyngeal Reflux: Diagnosis, Treatment, and Latest Research
Introduction Laryngopharyngeal reflux (LPR) is a highly prevalent disease and commonly encountered in the otolaryngologist's office. Objective To review the literature on the diagnosis and treatment of LPR. Data Synthesis LPR is associated with symptoms of laryngeal irritation such as throat clearing, coughing, and hoarseness. The main diagnostic methods currently used are laryngoscopy and pH m...
متن کاملProkinetic Agents and Laryngopharyngeal Reflux Disease
s of all retrieved studies. The full text of the selected studies were then analyzed to ensure that the following inclusion criteria were met: prospective study design, a patient population with a diagnosis of LPR, treatment arm including a prokinetic agent with or without the concomitant use of an antacid therapy (e.g., PPI or H2 antagonist), presence of a comparison arm, and treatment outcome...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Therapeutic Advances in Chronic Disease
سال: 2013
ISSN: 2040-6223,2040-6231
DOI: 10.1177/2040622313503485